These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26220878)

  • 21. Emerging Role of Melatonin and Melatonin Receptor Agonists in Sleep and Delirium in Intensive Care Unit Patients.
    Mo Y; Scheer CE; Abdallah GT
    J Intensive Care Med; 2016 Aug; 31(7):451-5. PubMed ID: 26092575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of ramelteon for treatment of visual hallucinations in dementia with Lewy bodies: a report of 4 cases.
    Kasanuki K; Iseki E; Nishida Y; Fujishiro H; Chiba Y; Sato K; Arai H
    J Clin Psychopharmacol; 2013 Aug; 33(4):581-3. PubMed ID: 23771196
    [No Abstract]   [Full Text] [Related]  

  • 23. [Melatonin, melatonin receptor agonists and tryptophan as sleep aids].
    Steinhilber D
    Pharm Unserer Zeit; 2007; 36(3):213-7. PubMed ID: 17555058
    [No Abstract]   [Full Text] [Related]  

  • 24. Adjunctive Valproic Acid in Management-Refractory Hyperactive Delirium: A Case Series and Rationale.
    Sher Y; Miller AC; Lolak S; Ament A; Maldonado JR
    J Neuropsychiatry Clin Neurosci; 2015; 27(4):365-70. PubMed ID: 25803136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty.
    Mini LJ; Wang-Weigand S; Zhang J
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):177-84. PubMed ID: 17996657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, placebo-controlled study of adjunctive ramelteon in ambulatory bipolar I disorder with manic symptoms and sleep disturbance.
    McElroy SL; Winstanley EL; Martens B; Patel NC; Mori N; Moeller D; McCoy J; Keck PE
    Int Clin Psychopharmacol; 2011 Jan; 26(1):48-53. PubMed ID: 20861739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of ramelteon on refractory behavioral and psychological symptoms of dementia in Alzheimer disease.
    Asano M; Ishitobi M; Tanaka Y; Wada Y
    J Clin Psychopharmacol; 2013 Aug; 33(4):579-81. PubMed ID: 23764686
    [No Abstract]   [Full Text] [Related]  

  • 28. Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial.
    Hatta K; Kishi Y; Wada K; Takeuchi T; Odawara T; Usui C; Nakamura H;
    JAMA Psychiatry; 2014 Apr; 71(4):397-403. PubMed ID: 24554232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic and treatment practices of delirium in a general hospital.
    Rooney S; Qadir M; Adamis D; McCarthy G
    Aging Clin Exp Res; 2014 Dec; 26(6):625-33. PubMed ID: 24789220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Postoperative delirium and cognitive deficit. Prevention and therapy].
    Heymann A; Spies C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2010 Feb; 45(2):112-6; quiz 117. PubMed ID: 20155641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ramelteon: a novel approach in the treatment of insomnia.
    Reynoldson JN; Elliott E; Nelson LA
    Ann Pharmacother; 2008 Sep; 42(9):1262-71. PubMed ID: 18648020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
    Roth T; Seiden D; Sainati S; Wang-Weigand S; Zhang J; Zee P
    Sleep Med; 2006 Jun; 7(4):312-8. PubMed ID: 16709464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-World Effectiveness of Ramelteon and Suvorexant for Delirium Prevention in 948 Patients With Delirium Risk Factors.
    Hatta K; Kishi Y; Wada K; Takeuchi T; Hashimoto N; Suda K; Taira T; Tsuchida K; Ohmori T; Akizuki N; Nishio Y; Nakanishi Y; Usui C; Kurata A; Horikawa N; Eguchi H; Ito S; Muto H; Nakamura H; Uchimura N
    J Clin Psychiatry; 2019 Dec; 81(1):. PubMed ID: 31851436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of ramelteon in Japanese adults with chronic insomnia: a randomized, double-blind, placebo-controlled study.
    Uchimura N; Ogawa A; Hamamura M; Hashimoto T; Nagata H; Uchiyama M
    Expert Rev Neurother; 2011 Feb; 11(2):215-24. PubMed ID: 21306209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pain, agitation, delirium, and neuromuscular blockade: a review of basic pharmacology, assessment, and monitoring.
    Altshuler J; Spoelhof B
    Crit Care Nurs Q; 2013; 36(4):356-69. PubMed ID: 24002426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnosis and treatment of delirium].
    Hepp U
    Praxis (Bern 1994); 2002 Mar; 91(11):455-63. PubMed ID: 11957740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insomnia: drug therapies #105.
    Arnold RM; Miller M; Mehta RS
    J Palliat Med; 2012 Feb; 15(2):243-4. PubMed ID: 22339330
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy of Ramelteon for delirium after lung cancer surgery.
    Miyata R; Omasa M; Fujimoto R; Ishikawa H; Aoki M
    Interact Cardiovasc Thorac Surg; 2017 Jan; 24(1):8-12. PubMed ID: 27624354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological treatment for the prevention of delirium: review of current evidence.
    Tabet N; Howard R
    Int J Geriatr Psychiatry; 2009 Oct; 24(10):1037-44. PubMed ID: 19226527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Psychiatrics emergencies].
    Nacht A
    Praxis (Bern 1994); 2005 Nov; 94(48):1925-6. PubMed ID: 16353691
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.